B-cell Malignancy
1 competing product in clinical development for B-cell Malignancy.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CD19-CAR-T cells | Avalon GloboCare | Phase 1 | Completed | 25 |
1 competing product in clinical development for B-cell Malignancy.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CD19-CAR-T cells | Avalon GloboCare | Phase 1 | Completed | 25 |